Human lung organoids (hLOs) are useful for disease modelling and drug screening. However, a lack of immune cells in hLOs limits the recapitulation of in vivo cellular physiology. Here, we generated hLOs containing alveolar macrophage (AMφ)-like cells derived from pluripotent stem cells (PSC). To bridge hLOs with advanced human lung high-resolution X-ray computed tomography (CT), we acquired quantitative micro-CT images. Three hLO types were observed during differentiation. Among them, alveolar hLOs highly expressed not only lung epithelial cell markers but also AMφ-specific markers. Furthermore, CD68 AMφ-like cells were spatially organized on the luminal epithelial surface of alveolar hLOs. Bleomycin-treated alveolar hLOs showed upregulated expression of fibrosis-related markers and extracellular matrix deposits in the alveolar sacs. Alveolar hLOs also showed structural alterations such as excessive tissue fraction under bleomycin treatment. Therefore, we suggest that micro-CT analyzable PSC-derived alveolar hLOs are a promising in vitro model to predict lung toxicity manifestations, including fibrosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907399PMC
http://dx.doi.org/10.1007/s10565-022-09698-1DOI Listing

Publication Analysis

Top Keywords

alveolar hlos
20
alveolar
9
hlos
9
micro-ct analyzable
8
psc-derived alveolar
8
human lung
8
amφ-like cells
8
cells
5
pulmonary fibrosis
4
fibrosis model
4

Similar Publications

Studies using human lung organoids (hLO) have focused on differentiation of lung epithelial subtypes into distal alveolar unit. A major question has been whether introducing endothelial cells (EC) and resultant vascularization alter development of hLO. We describe herein a method for vessel infiltration of hLO in which we determined differences of these hLOs with standard avascular hLOs.

View Article and Find Full Text PDF

Human lung organoids (HLOs) are enabling the study of human lung development and disease by modeling native organ tissue structure, cellular composition, and cellular organization. In this report, we demonstrate that HLOs derived from human pluripotent stem cells cultured in alginate, a fully defined nonanimal product substrate, exhibit enhanced cellular differentiation compared with HLOs cultured in the commercially available Matrigel. More specifically, we observed an earlier onset and increase in the number of multiciliated cells, along with mucus producing MUC5AC goblet-like cells that were not observed in HLOs cultured in Matrigel.

View Article and Find Full Text PDF

Human lung organoids (hLOs) are useful for disease modelling and drug screening. However, a lack of immune cells in hLOs limits the recapitulation of in vivo cellular physiology. Here, we generated hLOs containing alveolar macrophage (AMφ)-like cells derived from pluripotent stem cells (PSC).

View Article and Find Full Text PDF

Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression.

Int J Cancer

October 2021

Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Article Synopsis
  • Lung adenocarcinoma (LUAD) is a prevalent lung cancer arising from the terminal airway, and understanding its development is essential for creating new treatments.
  • Researchers utilized human induced pluripotent stem cells (hiPSCs) to create modified cells that overexpress the HER2 protein, leading to the formation of human lung organoids (HLOs) that mimic lung tissue.
  • These HLOs displayed characteristics of early tumor development, including increased irregularity and growth, and a gene expression profile that resembled that of LUAD with HER2 amplification, indicating their potential as a model for studying tumor initiation and progression.
View Article and Find Full Text PDF

Human embryonic stem cell (hESC) derived 3D human lung organoids (HLOs) provide a promising model to study human lung development and disease. HLOs containing proximal or/and immature distal airway epithelial cells have been successfully generated in vitro, such as early staged alveolar type 2 (AT2) cells (SPC/SOX9) and immature alveolar type 1 (AT1) cells (HOPX/SOX9). When HLOs were transplanted into immunocompromised mice for further differentiation in vivo, only few distal epithelial cells could be observed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!